ATE375996T1 - Sekretionsfordermittel fur wachtumshormon - Google Patents

Sekretionsfordermittel fur wachtumshormon

Info

Publication number
ATE375996T1
ATE375996T1 AT00913536T AT00913536T ATE375996T1 AT E375996 T1 ATE375996 T1 AT E375996T1 AT 00913536 T AT00913536 T AT 00913536T AT 00913536 T AT00913536 T AT 00913536T AT E375996 T1 ATE375996 T1 AT E375996T1
Authority
AT
Austria
Prior art keywords
growth hormone
secretion promoters
promoters
secretion
hormone
Prior art date
Application number
AT00913536T
Other languages
English (en)
Inventor
Jeffrey Dodge
Charles Lugar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE375996T1 publication Critical patent/ATE375996T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT00913536T 1999-02-19 2000-02-18 Sekretionsfordermittel fur wachtumshormon ATE375996T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12081399P 1999-02-19 1999-02-19

Publications (1)

Publication Number Publication Date
ATE375996T1 true ATE375996T1 (de) 2007-11-15

Family

ID=22392709

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00913536T ATE375996T1 (de) 1999-02-19 2000-02-18 Sekretionsfordermittel fur wachtumshormon

Country Status (13)

Country Link
EP (1) EP1153034B1 (de)
JP (1) JP2002539089A (de)
CN (1) CN1179972C (de)
AR (1) AR023369A1 (de)
AT (1) ATE375996T1 (de)
AU (1) AU765642B2 (de)
BR (1) BR0008321A (de)
CA (1) CA2362303A1 (de)
CO (1) CO5160260A1 (de)
DE (1) DE60036785D1 (de)
IL (1) IL144350A0 (de)
PE (1) PE20001468A1 (de)
WO (1) WO2000049037A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6639076B1 (en) 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
US6828331B1 (en) 1999-02-19 2004-12-07 Eli Lilly And Company Growth hormone secretagogues
CA2410597A1 (en) 2000-05-30 2001-12-06 Merck & Co., Inc. Melanocortin receptor agonists
US6756385B2 (en) * 2000-07-31 2004-06-29 Pfizer Inc. Imidazole derivatives
PY0117895A (es) * 2000-07-31 2003-11-03 Pfizer Prod Inc Derivados de imidazol
WO2002032878A1 (en) * 2000-10-13 2002-04-25 Eli Lilly And Company Resolution process for preparation of substantially pure (r) and (s) enantiomers of 2-(4-nitroimidazolyl)-4-methoxyphenylpropionic acid and salts thereof
CA2431515C (en) * 2001-01-23 2008-01-22 Gador S.A. Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition, and use thereof
US7125840B2 (en) 2001-10-09 2006-10-24 Eli Lilly And Company Substituted dipeptides as growth hormone secretagogues
EP1497316B1 (de) 2002-04-09 2006-07-05 Eli Lilly And Company Wachstumhormonsekretionsförderer
EP1730119B1 (de) 2004-03-23 2008-06-25 Pfizer Products Incorporated Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
JP2009508934A (ja) 2005-09-22 2009-03-05 ファイザー・プロダクツ・インク 神経障害治療のためのイミダゾール化合物
US11884634B2 (en) 2019-08-09 2024-01-30 Pfizer Inc. Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide
ES3055762T3 (en) 2019-08-09 2026-02-16 Pfizer Solid state forms of (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-n-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1h-imidazol-4-yl)pentanamide and uses thereof
WO2023034917A1 (en) 2021-09-01 2023-03-09 Springworks Therapeutics, Inc. Synthesis of nirogacestat
US11504354B1 (en) 2021-09-08 2022-11-22 SpringWorks Therapeutics Inc.. Chlorinated tetralin compounds and pharmaceutical compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107836A (en) * 1992-12-11 1998-01-04 Merck & Co Inc Spiro piperidines and homologues, their preparation and pharmaceutical preparations containing them
NZ258412A (en) * 1992-12-11 1997-01-29 Merck & Co Inc Spiro-fused piperidine derivatives and pharmaceutical compositions
US5721250A (en) * 1993-12-23 1998-02-24 Merck & Co. Inc. Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
WO1998016527A1 (en) * 1996-10-15 1998-04-23 Fujisawa Pharmaceutical Co., Ltd. Benzoxepine derivatives which promote release of growth hormone
ZA987385B (en) * 1997-08-19 2000-04-18 Lilly Co Eli Growth hormone secretagogues.
ZA987383B (en) * 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.

Also Published As

Publication number Publication date
JP2002539089A (ja) 2002-11-19
IL144350A0 (en) 2002-05-23
CN1179972C (zh) 2004-12-15
DE60036785D1 (de) 2007-11-29
CN1347420A (zh) 2002-05-01
EP1153034A1 (de) 2001-11-14
EP1153034B1 (de) 2007-10-17
CA2362303A1 (en) 2000-08-24
PE20001468A1 (es) 2000-12-20
BR0008321A (pt) 2002-01-29
WO2000049037A1 (en) 2000-08-24
AR023369A1 (es) 2002-09-04
CO5160260A1 (es) 2002-05-30
AU765642B2 (en) 2003-09-25
AU3496800A (en) 2000-09-04

Similar Documents

Publication Publication Date Title
ATE362472T1 (de) Wachstumhormonsekretionsförderer
DK0869968T3 (da) Væksthormonsecerneringsfremmende stof
ATE356139T1 (de) Dipeptidderivate zur förderung der sekretion von wachstumshormon
DE60115227D1 (de) Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga
NO20014407D0 (no) Heterosykliske aromatiske forbindelser nyttige som veksthormon sekresjons-stimulerende midler
ATE375996T1 (de) Sekretionsfordermittel fur wachtumshormon
NO20015178L (no) Sammensetning til en morsmelkserstatning med lavt threonininnhold
DK1176195T3 (da) Fremgangsmåde til at kontrollere aktiviteten af immunologisk funktionelt molekyle
NO20020191D0 (no) Applikator for reflexoterapi
DK1020195T3 (da) Sårbandage
ID30091A (id) Metode untuk menyiapkan l-fenilefrina hidroklorida
ES1044448Y (es) Auto-aplicador de vendaje
DE60024165D1 (de) Wischersteuervorrichtung
DK1223887T3 (da) Implantatindstilling
EP1158996A4 (de) Neue amidderivate als wachstumshormonsekretionsförderer
EE200000193A (et) Kasvuhormoonide sekreteerimist stimuleerivate ühendite valmistamise protsess
FR2791348B1 (fr) POLYPEPTIDE Npt2B
ATE381618T1 (de) Polypeptidhormon phosphatonin
SE514398E (sv) Förfarande vid spetsdragning
EP1174511A4 (de) Promotoren
DE60008041D1 (de) Beleuchtungsgeräte fur gewächshäuser
KR970056422U (ko) 농작물 재배용 이동체
FI991413A0 (fi) Yhteyden pystytysmenetelmä
FI4415U1 (fi) Perhouistin vapakalastukseen
FI991418A0 (fi) Kompostoitava kukkasieni

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties